Keros Therapeutics, Inc. · NASDAQ:KROS

Bienaime Jean Jacques bought 1,000 Keros Therapeutics, Inc. shares (Form 4)

Traded Jul 15, 2026 · Filed Jul 17, 2026

On Jul 15, 2026, Bienaime Jean Jacques (Director) bought 1,000 Keros Therapeutics, Inc. shares at US$10.61 for US$10,610 under a trading plan, leaving 18,592 shares. Filed Jul 17, 2026 (Form 4).

Bought
1,000 shares
Price
US$10.61
Value
US$10,610
Holding after
18,592 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Common StockBuy1,000US$10.6118,592Direct

Source

View original at SEC

Related